Common variants

In human genetics, a "variant" refers to any location in the genome where the DNA sequence differs among individuals. While millions of such variants exist, they are broadly categorized by their frequency. Common variants are those that have a minor allele frequency (MAF)—the frequency of the less common version of the variant—of over 1% to 5% in a given population. The most prevalent type of common variant is the single nucleotide polymorphism (SNP), which is a change in a single DNA base pair. These variants are generally ancient, having arisen thousands of years ago and spread widely as human populations grew and migrated.

The existence of common variants is a cornerstone of human diversity. Most have no discernible effect on health or physical traits. However, some can subtly influence an individual's characteristics or their susceptibility to certain conditions. Unlike rare variants, which can have large, deterministic effects and are often responsible for Mendelian (single-gene) disorders like cystic fibrosis, common variants typically exert very small individual effects. Their influence on health is often probabilistic, slightly increasing or decreasing risk rather than directly causing a disease.

The study of common variants is central to the "common disease-common variant" (CDCV) hypothesis, which posits that common, complex diseases like type 2 diabetes, coronary artery disease, and schizophrenia are influenced by the combined effects of many common genetic variants. This hypothesis is primarily investigated using Genome-Wide Association Studies (GWAS). In a GWAS, researchers scan the genomes of thousands of individuals, comparing those with a particular disease to those without, to identify common variants that are statistically more frequent in the affected group. These associations can pinpoint genes and biological pathways involved in the disease, even if the individual contribution of each variant is minor.

For patients and the public, the significance of common variants lies in their potential for risk prediction and personalized medicine. By aggregating the small effects of many disease-associated common variants, scientists can calculate a Polygenic Risk Score (PRS). A PRS estimates an individual's genetic predisposition to a specific condition, which could potentially inform screening schedules, lifestyle recommendations, or preventive treatments. Furthermore, identifying these variants helps researchers understand the fundamental biology of common diseases, opening new avenues for drug development. However, it is crucial to recognize that common variants are only one piece of the puzzle; they explain only a fraction of disease heritability, and risk is also heavily influenced by rare variants, environmental factors, and lifestyle choices.